GTC Biotherapeutics (fka GTCB)

[croumagnon]

Bottom line for GTC investors and prospective investors: You are now effectively a minority shareholder with no protection from exploitation by the majority owner, LFB. If you continue to invest in GTC in spite of this, you deserve what you get.

This is true but the minority shareholders of Genentech did quite well over the years as you know...